Navigation Links
Medication Management Systems Names New President and COO
Date:2/27/2008

MINNEAPOLIS, Feb. 27 /PRNewswire/ -- Medication Management Systems (MMS), a leading player in medication therapy management throughout the U.S., today announced the appointment of Nathan J. Schultz, Pharm.D. to the newly created executive position of President and Chief Operating Officer.

"The Board of Directors and staff of MMS are honored that Nate has agreed to join in helping us continue to develop new services and technologies that promote efficacy, safety, and adherence in the appropriate use of medications," said Chairman of the Board David J. McLean, Ph.D. "As a 25-year veteran and recognized innovator in managed care pharmacy and pharmaceutical benefit management, I am confident that Nate will be able to contribute immediately and provide experienced, executive leadership and counsel to both the staff and the Board."

Dr. Schultz is a clinical pharmacist with over 25 years experience in hospital and academic settings, in addition to his leadership in the managed care pharmacy and pharmacy benefit management arena. Formerly Chief Services Officer of National Medical Health Card Systems, his background includes over 10 years in various leadership positions with Diversified Pharmaceutical Services and Express Scripts, and as Senior Vice President of Sales at Caresoft, Inc., a venture capital-backed internet healthcare company. Founding principal of The BayPine Consultancy, a private practice executive management firm specializing in strategic planning and operations management for healthcare and pharmaceutical-related businesses, he holds both a Bachelor of Science and Doctor of Pharmacy degree from the University of Minnesota and is certified as a Pharmacotherapy Specialist by the Board of Pharmaceutical Specialties.

About Medication Management Systems

Medication Management Systems (MMS) is a national leader in designing and delivering evidence-based medication therapy management (MTM) programs. A Minnesota-based company, MMS
'/>"/>

SOURCE Medication Management Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Tips for Troublesome Medications, From the Harvard Heart Letter
2. First DataBank Launches Campaign to Focus Public and Industry Attention on Medication Error Prevention
3. Depression in Young Doctors Tied to Medication Errors
4. Gene variant predicts medication response in patients with alcohol dependence
5. U.S. Pharmacopeia 8th Annual MEDMARX(R) Report Indicates Look-Alike/Sound-Alike Drugs Lead to Thousands of Medication Errors Nationwide
6. American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine Medications
7. AASM statement on use of sleep medications
8. Genetics Influence Blood Pressure Medications
9. FLAVORx Teams up with Wedgewood Pharmacy to Make it Even Easier to Make Pet Medications Taste Good
10. Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone
11. Uses of medications in psychoanalysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...Discrimination Safeguards to Ensure Patient Access...ire-USNewswire/ -- The American Optometric Associa...e providers of eye and vision care in America, and...s, Access to Responsible Care Alliance (PARCA) tod...ressional leaders to support legislation to increa...
(Date:12/4/2008)...BAPTIST HEALTH, a six-hospital,system based in Li...stem, has,expanded its use of Clinical Xpert(TM) ... enabled the system,s pharmacists to increase nece...1 million. , "Data we collected for the 220... prompts approximately half of the pharmacy clinic...
(Date:12/4/2008)...io study of 491 women with invasive ovarian cancer... for genetic testing of BRCA1 and BRCA2, the breas... informed of their cancer risk. , Dr. Kelly Met... Toronto,s Lawrence S. Bloomberg Faculty of Nursin...earch Institute, led the nursing study, which was ...
(Date:12/4/2008)...and on the eve of its 35th Anniversary, Ronald McD...ated Season of Giving marketing campaign to remind... initiative, designed to drive personal donations,... three core programs: Ronald McDonald House, Ronal...e Mobile. , OAK BROOK, I...
Breaking Medicine News(10 mins):Health News:AOA-Led Group Urges Obama to Increase Health Care Access, Affordability by Combating Provider Discrimination 2Health News:AOA-Led Group Urges Obama to Increase Health Care Access, Affordability by Combating Provider Discrimination 3Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 2Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 3Health News:Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes 2Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 2Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 3
...kungunya and dengue fever in the state has been br...Aedes aegypti, mosquito is the common carrier of b...irus. Hence, the state has taken up an integrated ...000 health workers and volunteers. All the water s...
...ed that extreme and prolonged stress could lead to... to switch off, could lead to grave health problem...und that not being able to sleep is a top worry fo...g with every day life. They are not so much concer...
...d on the street, causes the abnormal buildup of pr...ng heart enlargement that can ultimately lead to s...y of South Florida College of Medicine and James A... was published in the July 2006 issue of the Journ...
... eight times more likely to injure their knee's an...nterparts, according to a recent study led by Morg...terian and Columbia University Medical Center. Pub..., the study looks at the reasons why the knee inju...
Other Medicine News:Health News:Researchers Identify Key Step in Cocaine-Induced Heart Enlargement, Sudden Death 2Health News:Adolescent Girl Athletes More Likely to Injure Knees Than Boys 2
(Date:12/4/2008)...AM, December 4 Biopharmaceutical c...successfully completed treatment of the,last pati...R(TM), a donor,lymphocyte cell based product, is ...ost Disease (GvHD) and allow early immune reconsti...antation. Nineteen end stage blood cancer,patient...
(Date:12/3/2008)... N.J., Dec. 4 Roche today announce... has provided further guidance on the requirements...CTEMRA(R) (tocilizumab), the first interleukin-6 (...ied for the treatment of adult patients with moder.... , , As a result of the FDA,s evolving Ri...
(Date:12/3/2008)... Del., Dec. 3 Isogen, a contract d...rile filling, announced it has retained a,strateg...to meet the global,biopharma demand for Isogen,s ... a successful first round series of capital,inves...cility in Q1 2009 to,deliver on the previously un...
(Date:12/2/2008)..., Dec. 3 Breast-specifi...ion of cancers not found on mammograms or by,clin... the annual meeting of,the Radiological Society o...y the most difficult to detect breast cancer-invas.... Brem, M.D., professor of,radiology and director...
Breaking Medicine Technology:Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations 2Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 2Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 3Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 4Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 5Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3QLT Completes Acquisition of ForSight Newco II Inc 4106 1QLT Completes Acquisition of ForSight Newco II Inc 4106 2QLT Completes Acquisition of ForSight Newco II Inc 4106 3Congress and the President Must Act to Secure Peace of Mind for Americas Laboring Families 4101 1Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 1Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 2Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 3Exposure to sunlight may decrease risk of advanced breast cancer by half 4099 1Exposure to sunlight may decrease risk of advanced breast cancer by half 4099 2Exposure to sunlight may decrease risk of advanced breast cancer by half 4099 3
...-Apr 26, 2007 - Northfield,Laboratories Inc. (Nasd...ch organization has informed the Company that the ...III trauma trial with,PolyHeme(R), the Company,s h...stitute, will not be complete until May., About No...c. is a leader in developing an,oxygen-carrying re...
...monstrates dramatic,benefits of adding Diovan to c...o superior outcomes for,Diovan patients , , , B...from the independent,Jikei Heart Study, published ... pressure lowering medication Diovan® to,conve...in,cardiovascular events and a 40% reduction in st...
Other Medicine Technology:Northfield Laboratories Investor Update 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7
Straight 21 mm serrated jaws. Ring handle with ratchet lock. Non-magnetic and dull finish. Overall length 4.8 inches.
Shafts angled 45 degrees with 10 mm jaws. Serrated handle with polished finish. Smooth jaws. Most popular size or model.
Straight shafts with 16 mm long platform. Lengthwise serrated jaws with cross serrated tips. Serrated handle with polished finish. Platform: 2.4 mm wide.
Straight shafts with 6.5 mm tying platform. Crisscross serrated 1mm tips. Scalloped handle with dull finish.
Medicine Products: